Shobha Ullas Kamath1, Abhishek Chaturvedi2, Devesh Bhaskar Yerrapragada1, Nagendra Kundapura1, Navaneeth Amin1, Virupaksha Devaramane3. 1. Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal -576104, Karnataka, India. 2. Department of Biochemistry, Melaka Manipal Medical College (Manipal campus), Manipal Academy of Higher Education, Manipal -576104, Karnataka, India. 3. Department of Psychiatry, Dr. A.V. Baliga Memorial Hospital, Doddanagudde, Udupi, Karnataka, India.
Abstract
BACKGROUND: Depression is a common and widespread mood disorder, which affects an emotional level that varies widely in its intensity. Biochemical parameter alterations have been observed in different depression types. In the present study, we examined acetylcholinesterase (AChE), paraoxonase 1 (PON1), and copper levels in moderately-depressed patients and healthy controls to ascertain whether the measurement of red blood cell (RBC) AChE, and plasma PON1 and copper could be used to evaluate moderate depression. METHODS: This case control study was performed in the Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India. Patients who met ICD 10 diagnostic criteria were considered as cases. Goldberg's General Health Questionnaire 28 (GHQ-28) was used to select controls. Four ml of blood was collected from 24 cases and 20 controls aged 35-70 years and used to determine RBC AChE, and plasma PON1 and copper levels. RESULTS: Red blood cell AChE, and plasma PON1 and copper levels were significantly greater in patients with moderate depression than in controls. Further, a receiver operating characteristic curve for validity of the biochemical parameters in plasma from patients with moderate depression indicated sensitivity and specificity above 85% for copper and PON1. CONCLUSION: Red blood cell AChE, plasma PON1, and copper levels may have roles in the pathogenesis of depressive disorders.
BACKGROUND: Depression is a common and widespread mood disorder, which affects an emotional level that varies widely in its intensity. Biochemical parameter alterations have been observed in different depression types. In the present study, we examined acetylcholinesterase (AChE), paraoxonase 1 (PON1), and copper levels in moderately-depressed patients and healthy controls to ascertain whether the measurement of red blood cell (RBC) AChE, and plasma PON1 and copper could be used to evaluate moderate depression. METHODS: This case control study was performed in the Department of Biochemistry, Kasturba Medical College, Manipal Academy of Higher Education, Manipal, Karnataka, India. Patients who met ICD 10 diagnostic criteria were considered as cases. Goldberg's General Health Questionnaire 28 (GHQ-28) was used to select controls. Four ml of blood was collected from 24 cases and 20 controls aged 35-70 years and used to determine RBC AChE, and plasma PON1 and copper levels. RESULTS: Red blood cell AChE, and plasma PON1 and copper levels were significantly greater in patients with moderate depression than in controls. Further, a receiver operating characteristic curve for validity of the biochemical parameters in plasma from patients with moderate depression indicated sensitivity and specificity above 85% for copper and PON1. CONCLUSION: Red blood cell AChE, plasma PON1, and copper levels may have roles in the pathogenesis of depressive disorders.
Authors: Michael Maes; Piotr Galecki; Yong Seun Chang; Michael Berk Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2010-05-12 Impact factor: 5.067
Authors: M Berk; F Kapczinski; A C Andreazza; O M Dean; F Giorlando; M Maes; M Yücel; C S Gama; S Dodd; B Dean; P V S Magalhães; P Amminger; P McGorry; G S Malhi Journal: Neurosci Biobehav Rev Date: 2010-10-08 Impact factor: 8.989
Authors: Charles F Reynolds; Mary Amanda Dew; Bruce G Pollock; Benoit H Mulsant; Ellen Frank; Mark D Miller; Patricia R Houck; Sati Mazumdar; Meryl A Butters; Jacqueline A Stack; Mary Ann Schlernitzauer; Ellen M Whyte; Ariel Gildengers; Jordan Karp; Eric Lenze; Katalin Szanto; Salem Bensasi; David J Kupfer Journal: N Engl J Med Date: 2006-03-16 Impact factor: 91.245